Cargando…
Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in the United States with a five-year survival rate of 7.2% for all stages. Although surgical resection is the only curative treatment, currently we are unable to differentiate between resectable patients with occult metastati...
Autores principales: | Chakraborty, Jayasree, Langdon-Embry, Liana, Cunanan, Kristen M., Escalon, Joanna G., Allen, Peter J., Lowery, Maeve A., O’Reilly, Eileen M., Gönen, Mithat, Do, Richard G., Simpson, Amber L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720792/ https://www.ncbi.nlm.nih.gov/pubmed/29216209 http://dx.doi.org/10.1371/journal.pone.0188022 |
Ejemplares similares
-
Basket Trials in Oncology: A Trade-Off Between Complexity and Efficiency
por: Cunanan, Kristen M., et al.
Publicado: (2017) -
Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma
por: Yu, Kenneth H., et al.
Publicado: (2018) -
Online synchronous chat counselling for young people aged 12–25: a mixed methods systematic review protocol
por: Tibbs, Maria, et al.
Publicado: (2022) -
Experiences of early graduate medical students working in New York hospitals during the COVID-19 pandemic: a mixed methods study
por: Pravder, Harrison D., et al.
Publicado: (2021) -
Correction to: Experiences of early graduate medical students working in New York hospitals during the COVID-19 pandemic: a mixed methods study
por: Pravder, Harrison D., et al.
Publicado: (2021)